Core Insights - Evernorth, the health services division of The Cigna Group, has introduced a new rebate-free pharmacy benefit model aimed at lowering costs and improving transparency for Americans while supporting local pharmacies [1][2][12] Summary by Sections New Pharmacy Benefit Model - The new model eliminates the complex post-purchase rebate process, allowing discounts negotiated with drug companies to be available upfront to consumers [2][3] - This approach is expected to reduce monthly costs for brand-name prescriptions by an average of 30% for individuals with high-deductible health plans [3][4] Cost Reduction and Transparency - Evernorth's model ensures that Americans pay the lowest available cost for both brand-name and generic medicines by leveraging technology to compare multiple pricing options [4][5] - For example, a negotiated cost of $22 (70% off the list price) and a cash discount of $20 illustrate the potential savings for consumers [5] Support for Local Pharmacies - Evernorth is adopting a new reimbursement model that compensates local pharmacies based on their costs plus a dispensing fee, recognizing the essential clinical services they provide [9][10] - This model will be implemented across all in-network pharmacies starting in 2026, ensuring that local pharmacies have the resources to excel in patient care [11] Commitment to Innovation - The new pharmacy benefit model builds on Evernorth's legacy of driving affordability and access to medications, including the use of generics and biosimilars [12][13] - The company aims to continue innovating to improve health outcomes for millions of Americans [12]